NOVTU
NOVANTA INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest +2.0% to 53.1K shares. 1.0 days to cover, ≈0.1% of shares.
- TrendRANGE
1% above its 50-day average.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $301.0M |
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | — | — | — | $1.1B |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Sep 30, 2026SecBot reports
3 filings · 1 bullish · 0 bearish · 2 neutral- NEUTRAL 8-KJun 9, 2026
Novanta Inc. entered into a securities purchase agreement for a private placement of 2,142,857…
The $300M capital raise provides Novanta with substantial balance sheet flexibility, but the lack of disclosed use of proceeds creates uncertainty. Monitor for an acquisition announcement or debt…
- BULLISH 8-KJun 9, 2026
Novanta (NOVT/NOVTU) entered a definitive agreement to acquire Riverpoint Medical (from Arlington…
Expect a positive initial reaction as the deal is immediately EPS-accretive and shifts Novanta's mix toward higher-growth, recurring medical consumables. Monitor HSR clearance timeline (150-day…
- NEUTRAL 144May 5, 2026
Officer Matthijs Glastra filed a Form 144 indicating intent to sell 6,500 shares of Novanta common…
This is a routine insider sale consistent with a pre-arranged trading plan. No immediate action needed; monitor for any deviation from the established pattern or change in selling frequency ahead of…
All NOVTU filing & press-release reports (3)
- 8-K reportJun 9, 2026
- 8-K reportJun 9, 2026
- 144 reportMay 5, 2026